Clinical trial
SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or…
NCT00002960 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00002960 |
|---|---|
| Title | SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) |
| Official title | A Phase I Study in Patients With Peritoneal Carcinomatosis Using SCH 58500 (rAd/p53) Administered by Single Intraperitoneal Instillation |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Biological |
| Interventions | recombinant adenovirus-p53 SCH-58500 |
| Enrollment | 59 |
| Start date | Jun 1, 1999 |
| Primary completion | Jul 1, 2000 |
| Completion | Jul 1, 2000 |
| First posted | Aug 24, 2004 |
| Last update posted | Feb 4, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: